Sign in bar not supported by browser
Skip to Content
Request an appointment
Keyword
In a major international study led by researchers at The University of Texas MD Anderson Cancer Center, the targeted therapy ibrutinib continues to show remarkable promise for the treatment of relapsed or refractory mantle cell lymphoma (MCL). (06/19/2013 )
Researchers have discovered and mapped the signaling network between two previously unconnected proteins, exposing a link that, if broken, could cut off cancer cell growth at its starting point. (06/18/2013)
Avoid cancer-causing agents when you barbecue by using the healthy grilling tips in the new infographic, How to fill a healthy barbecue plate. (06/11/2013)
Search News
View all News Releases from MD Anderson
See all publications